Renal 1,25(OH)2D production in humans is normally enhanced by PTH, hypocalcaemia, and hypophosphatemia and inhibited by 1,25(OH)2D and fibroblast growth factor 23 (FGF23). Here, PTH is linked to Hypocalcemia.